Physician

Ahmad Al Nakshabandi, M.D

According to 2025 Medicare claims, Ahmad Nakshabandi, M.D (NPI: 1346691383) practices gastroenterology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is IMAD AL-NAKSHABENDI M D P A (NPI: 1093995821; TIN: 020732411) and primary practice location at 33544-9207. Nakshabandi is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Nakshabandi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 403 traditional Medicare patients, billed 1,168 HCPCS/CPT codes, and received $114,470 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 131 prescription claims across 74 beneficiaries totaling $6,501 in drug costs, led by Pantoprazole Sodium (Pantoprazole Sodium). Open Payments data shows 26 records totaling $1,300. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $3,022 to $6,501. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$57K$114K2023 Medicare payment: $37,922 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $114,470 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023141330$37,922
20244031,168$114,470

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$24K2016 Drug cost: $3,022 (USD; Tot_Drug_Cst)2017 Drug cost: $14,267 (USD; Tot_Drug_Cst)2018 Drug cost: $23,960 (USD; Tot_Drug_Cst)2019 Drug cost: $16,769 (USD; Tot_Drug_Cst)2020 Drug cost: $2,806 (USD; Tot_Drug_Cst)2021 Drug cost: $3,040 (USD; Tot_Drug_Cst)2022 Drug cost: $8,409 (USD; Tot_Drug_Cst)2024 Drug cost: $6,501 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161859$3,022
201740236$14,267
201862318$23,960
201951199$16,769
20204061$2,806
20212844$3,040
2022N/R21$8,409
2023N/RN/RN/R
202474131$6,501

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes114117$133
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes125301$91
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more169180$86
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope9094$80
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's113117$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Pantoprazole SodiumPantoprazole Sodium542,564$454
FamotidineFamotidine14660$131
OmeprazoleOmeprazole16840$112

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$1,300Ovesco Endoscopy USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmad Al Nakshabandi, M.D?

Tedicare shows public-source Medicare data for Ahmad Al Nakshabandi, M.D (NPI 1346691383), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Al Nakshabandi, M.D have ACO affiliation data?

Ahmad Al Nakshabandi, M.D is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Ahmad Al Nakshabandi, M.D?

Ahmad Al Nakshabandi, M.D is linked to IMAD AL-NAKSHABENDI M D P A (billing NPI 1093995821) in the available physician profile data.

Does Ahmad Al Nakshabandi, M.D have Open Payments data?

Ahmad Al Nakshabandi, M.D has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.